OMASP.HEOMASP.HEHEL
Loading
EBITDA Over TimeContracting
Percentile Rank60
3Y CAGR-7.8%
5Y CAGR+6.6%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-7.8%/yr
vs +28.7%/yr prior
5Y CAGR
+6.6%/yr
Recent deceleration
Acceleration
-36.6pp
Decelerating
Percentile
P60
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$60.11M-28.0%
2024$83.44M-43.1%
2023$146.53M+90.8%
2022$76.81M-17.9%
2021$93.58M+114.5%
2020$43.63M+13.9%
2019$38.29M+36.9%
2018$27.96M-15.8%
2017$33.20M+43.4%
2016$23.15M-